Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. - Wikidata - wikimedia - TriplyDB

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.

http://www.wikidata.org/entity/Q34417017

about

Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art From selection hits to clinical leads: progress in aptamer discovery MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations siRNA Delivery by Stimuli-Sensitive Nanocarriers Unexpected origins of the enhanced pairing affinity of 2'-fluoro-modified RNA Knocking down disease: a progress report on siRNA therapeutics Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine Silencing disease genes in the laboratory and the clinic Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.Chemical modification: the key to clinical application of RNA interference?Applications of mass spectrometry to the study of siRNA.Advances in Systemic siRNA Delivery Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9.Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters.Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.Efficient and targeted delivery of siRNA in vivo.Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.RNA interference for improving the outcome of islet transplantation.RNAi induces innate immunity through multiple cellular signaling pathways.siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.The therapeutic potential of RNA interference.The silent treatment: siRNAs as small molecule drugs.Silencing neurodegenerative disease: bringing RNA interference to the clinic.RNAi for treating hepatitis B viral infection.Unique gene-silencing and structural properties of 2'-fluoro-modified siRNAs.Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.Interfering with disease: a progress report on siRNA-based therapeutics.Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.Rational design of novel N-alkyl-N capped biostable RNA nanostructures for efficient long-term inhibition of gene expression

P2860

Q26751229-1ED94BAA-F277-465D-B331-541C57DEFC06 Q26752799-BC21EE82-3981-441F-BD4E-535B85AD75E7 Q26773183-6FA2BF6A-471C-44E9-925C-1F72D8267678 Q26781212-732DCB5E-0585-4AB8-ABA7-E63096B064A4 Q27666384-D56143DF-643E-4D0A-B711-4E4CAE4C7B46 Q28082939-1C742763-C97C-4479-8F9E-514AF72F5055 Q28390007-83EAC4C2-01E7-4055-93D3-6FCAC637B321 Q29039090-72D2531B-0F9C-4B58-82B7-5B954F288C68 Q30502702-DB4FA0F6-C22B-4665-989E-60845D52BDFD Q33308712-DFE5F62B-71D5-4CE2-AEB1-7BFAD549AD88 Q33536680-8630B5C7-0138-40D7-A251-02DB6C9BE04D Q33613316-0814B905-4293-4EAB-B075-A73B082FD9FE Q33713259-C65EFDC7-FB41-428D-8DDC-CC2BF301A893 Q34020246-B9F09941-3776-448A-A6BB-BD1E9261D7DF Q34080079-B1D99063-41AE-41C2-BAEA-FAD0E16E0212 Q34102905-27A8D4F6-F979-4C0C-9D31-9AEAE28A0B9F Q34123971-93079C7A-1616-4BF4-9710-EBD2247EC649 Q34149828-1FC915D9-FFF6-491F-8F4D-1EFC8605A9A2 Q34436572-2D7FADED-DB7E-4728-A55F-C4C8E221A309 Q34729434-8BD69724-28F3-4222-8ABB-A86618042605 Q34735628-B81BE08B-6EE6-4C7E-8B1D-A98AD6911D37 Q34955791-9D025AEF-1B2B-4AEE-BFF5-461032B03A7B Q35086107-4C9176EF-9724-4A9A-9D25-26F0D2257B49 Q35179033-D797A65C-B52B-442F-B920-58A53CC20120 Q35681765-87F81703-959E-446A-8547-67BB2AA30942 Q35691719-4619F99B-B5E5-46D3-BA4E-F00F8AD7E662 Q35697443-5F2C86EE-6023-4B88-9459-9EAC1F7D3722 Q35806350-5D54DC1C-D4C3-4D44-8E0A-CE32C7AF2A99 Q35928850-F13E3718-EAC3-40F0-8C84-D690A22AC032 Q36174842-0BBD2F50-B805-4041-9C63-0DF5FF5CBB4B Q36237868-C0D216D6-716F-407B-A154-87AC57AAF9B0 Q36362370-000C655F-CD3B-4FC5-8B41-BBD0750B31C6 Q36390831-27938BD5-9263-4A49-A9AC-82CEFB26E152 Q36412870-42F97706-C4CC-4DE9-B9AF-BD6B7097CB37 Q36452421-E4EF053F-D76F-47B6-BEFB-CE13989DFFE7 Q36587576-48E89C0B-E458-41A9-9ABF-837356FA1223 Q36821357-6AE93773-C8B0-4883-A4D6-E167B0ED146F Q36836598-79543B5D-DAFF-4D28-9EC5-733B6C81DD04 Q36838803-B5167200-52DD-4C9B-93C2-962767FCC56E Q36914607-ABA5261E-5D66-451E-A705-68F95F7DFA09

P2860

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.

http://www.wikidata.org/entity/Q34417017

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Activity of stabilized short i ...... hepatitis B virus replication.

@ast

Activity of stabilized short i ...... hepatitis B virus replication.

@en

Activity of stabilized short i ...... hepatitis B virus replication.

@nl

type

label

Activity of stabilized short i ...... hepatitis B virus replication.

@ast

Activity of stabilized short i ...... hepatitis B virus replication.

@en

Activity of stabilized short i ...... hepatitis B virus replication.

@nl

prefLabel

Activity of stabilized short i ...... hepatitis B virus replication.

@ast

Activity of stabilized short i ...... hepatitis B virus replication.

@en

Activity of stabilized short i ...... hepatitis B virus replication.

@nl

P1433

Q34417017-2532DD09-1A8C-4117-8C89-5BC89B13BDA1

P1476

Q34417017-0C65A1CF-BF90-474E-BAD6-2B286E70AEC4

P2093

Q34417017-0F6FB4E1-99EC-440F-8500-018028F8A0F3

Q34417017-1C5DF828-3F30-42B1-9018-EF0513E7CB0D

Q34417017-629DD66C-BE44-434C-A201-78B601ADD387

Q34417017-66FE3191-6190-4834-AEDC-A83A145BB398

Q34417017-7B56F4B0-8E1D-4756-AC3E-2728BDDE8E81

Q34417017-8BACE1FB-1A59-4E0C-ADB1-9420E8D26E53

Q34417017-9AD83FB0-B7CB-4473-82A6-3836D73E2CB8

Q34417017-A4E8F4B6-3728-43D2-907C-984798E2EACF

Q34417017-ACFE684A-446B-4103-A0EB-C44F99F04754

Q34417017-CE0773BB-FE2D-46AE-983B-7F9EA2F48C58

P2860

Q34417017-7405B375-AA64-439C-B041-D16EF069A2C8

P304

Q34417017-717CB879-D624-4EC5-9AF5-E8801CA4E4A0

P31

Q34417017-894A7AE6-1489-4954-A338-A497FEB706B8

P356

Q34417017-33B78515-356E-43EC-AAFB-50F194354194

P407

Q34417017-82AFC79C-3E7E-4803-A813-CA7EC4925504

P433

Q34417017-FD913E14-3AA6-40C3-86BC-75FD4A72786A

P478

Q34417017-63C4AD3B-3847-4609-93FA-63F4386F6986

P577

Q34417017-0159543E-BA8D-4ABB-B17A-2F35DE5E4716

P5875

Q34417017-1CF4A25A-4F7D-496F-9CB6-B03C22BFBD42

P698

Q34417017-63EC783A-AB1E-4F56-8787-DEEC452FD84A

P356

P1433

P1476

Activity of stabilized short i ...... hepatitis B virus replication.

@en

P2093

Barry A Polisky

http://www.w3.org/2001/XMLSchema#string

Brent Dickinson

http://www.w3.org/2001/XMLSchema#string

Chandra Vargeese

http://www.w3.org/2001/XMLSchema#string

Chris S Shaffer

http://www.w3.org/2001/XMLSchema#string

David V Morrissey

http://www.w3.org/2001/XMLSchema#string

James A McSwiggen

http://www.w3.org/2001/XMLSchema#string

Jennifer A Lockridge

http://www.w3.org/2001/XMLSchema#string

Karin Blanchard

http://www.w3.org/2001/XMLSchema#string

Keith Bowman

http://www.w3.org/2001/XMLSchema#string

Kristi Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference.

P304

1349-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.20702

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7859705

http://www.w3.org/2001/XMLSchema#string

P698

15880588

http://www.w3.org/2001/XMLSchema#string